Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human...
Transcript of Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human...
![Page 1: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/1.jpg)
13.10.2012
Innovative Biotechnologies for Human Healthcare
Prof. Theo DingermannInstitut für Pharmazeutische Biologie
BiozentrumMax-von Laue-Str. 9
60438 Frankfurt am [email protected]
Setting the SceneFrom Copying Towards Designing
![Page 2: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/2.jpg)
Prof. Dr. Theodor Dingermann – Personalized Medicine
Mortality 1889 and 1992
![Page 3: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/3.jpg)
1900: ca. 7 % of the 9 % living were healthy, i.e. 2 % were ill2000: ca. 30 % of the 58 % living are healthy, i.e. 28 % are ill
Mortality and Morbidity 1889 and 1992
![Page 4: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/4.jpg)
Available drugs at the beginning of the 20th century:
Times of Pharmaceutical Revolutions...
• Acetylsalicylic (Aspirin®)• Aminopyrine (Pyramidon®)• Arsphenamine (Salvarsan®)• Barbital (Veronal®)• A Diphtheria Serum• Morphine• Procaine (Novocain®)• Strophanthine (Kombetin®)• Several Plant preparations
Modern drug development started in the mid 50th of the 20th
century!
![Page 5: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/5.jpg)
Discovery of DNA as a universal coding concept of all biological systems in 1953.
Bob Weinberg (MIT)„With the discovery of the DNA double helix by Watson and Crick, biology became an exact science “.
Times of Biological Revolutions...
![Page 6: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/6.jpg)
Discovery of DNA as a universal coding concept of all biological systems in 1953.
Cracking the genetic code in 1961 and the realization that this code is a universal code.
Times of Biological Revolutions...
![Page 7: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/7.jpg)
Rekombinant Proteins
Genetic information unit = universally
understood in allbiological organisms
”Target"-organism
”Source"-organism
![Page 8: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/8.jpg)
Rekombinant Proteins
Genetic information unit = universally
understood in allbiological organisms
Control units = extremely specific
”Target"-organism
”Source"-organism
![Page 9: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/9.jpg)
Rekombinant Proteins
”Source"-organism
”Target"-organism
"genetic engineering"Control units Information unit
Geneticallymodified organism
(GMO) Extraction undpurification
![Page 10: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/10.jpg)
Rekombinant Proteins
197 Biopharmaceuticals in the market by the end of 2011
mABs
27
Insulins Epoetin
100
50
0
32
8
Hormones
21
Enzymes
11
Clotting-factors
12
Interferons
9
Other
12
Vaccines
56
114
![Page 11: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/11.jpg)
Indications for Biologicals
• Anemia• Angiogenesis Inhibition /
Macular Degeneration (AMD)• Antithrombotic• Asthma• Bacterial/viral Infections• Cancer• Chronic Inflammation • Coagulation Disorders• Diabetes• Fertility Disorder• Fractures• Growth Disorders• Immune Prophylaxis
• Impaired Wound Healing• Infarction/Stroke• Lysosomal Storage Diseases• Metabolic Disorders• Mucosal Inflammation• Multiple Sclerosis• Osteoporosis• Paroxysmal Nocturnal
Hemoglobinuria• Psoriasis• Respiratory Infections• Rheumatism• Sepsis• Transplantation
![Page 12: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/12.jpg)
Rekombinant Drugs
At first glance it seems obvious:•recombinant drugs correspond to a natural, human molecule!
The second view shows:•A significant number of approved recombinant drugs does not correspond to a natural, human molecule!
![Page 13: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/13.jpg)
• Some modifications are concessions to the technical feasibility – sometimes gaining significant clinical improvement (product generation 1a).
• Some molecules are in fact identical to human biomolecules (product generation 1b).
• Some intended modifications improve the clinical performance compared to the natural counterparts, partly because they take into account the significant differences between the physiological and the therapeutic delivery (2nd generation products).
• Some molecules are simply “newly invented" (3rd generation products).
Different „Product Generations"
![Page 14: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/14.jpg)
Met-Somatropin (Protropin®)
H H
G
I E K D KR
M
Growth hormone
![Page 15: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/15.jpg)
Somatropin
H H
G
I E K D KR
Growth hormone
![Page 16: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/16.jpg)
Pegylated Somatropin
H H
G
I E K D KR
longer half-lifeModified growth hormone
![Page 17: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/17.jpg)
Pegvisomant (Somavert®)
H H
G
I E K D KR
D D
NARST
KS
Growth hormone GH Receptor Antagonist
![Page 18: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/18.jpg)
Anchor Innovation: „Genetically Modified Antibodies“
![Page 19: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/19.jpg)
Anchor Innovation: „Genetically Modified Antibodies“
![Page 20: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/20.jpg)
Anchor Innovation: „Genetically Modified Antibodies“
![Page 21: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/21.jpg)
Anchor Innovation: „Genetically Modified Antibodies“
![Page 22: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/22.jpg)
TNF Antagonists
Remicade®
(Infliximab)
![Page 23: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/23.jpg)
TNF Antagonists
Remicade®
(Infliximab)
Humira®
(Adalimumab)
![Page 24: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/24.jpg)
TNF Antagonists
Enbrel®(Etanercept)
Remicade®
(Infliximab)
Humira®
(Adalimumab)
![Page 25: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/25.jpg)
TNF Antagonists
Enbrel®(Etanercept)
Remicade®
(Infliximab)
Humira®
(Adalimumab)Cimzia®
(Certolizumab)
![Page 26: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/26.jpg)
TNF Antagonists
Enbrel®(Etanercept)
Remicade®
(Infliximab)
Humira®
(Adalimumab)Cimzia®
(Certolizumab)
Pegsunercept
![Page 27: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/27.jpg)
Medical Progress is Expensive – Very Expensive ..
![Page 28: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/28.jpg)
Medical Progress is Expensive – Very Expensive ..
INN Therapy costs Therapy costs
Human-Insuline per year ca. 420 €
Modified Insuline per year ca. 600 €
Cetuximab (Erbitux®) per month ca. 5.000 € initially,there after ca. 4.500 €
Trastuzumab (Herceptin®)(metastatic Mamma-CA)
per month ca. 3.400 € initially,thereafter ca. 2.800 €
Bevacizumab (Avastin®)(Mamma-CA)
per month 2 x 10 mg/kg ca. 6.600 €
Bevacizumab (Avastin®)(Colon-CA)
per month 2 x 5 mg/kg ca. 3.300 €2 x 10 mg/kg ca. 6.600 €
![Page 29: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/29.jpg)
… Because Medical Progress Ignores Moore‘s Law!
![Page 30: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/30.jpg)
Moore‘s Law
The number of transistors that can be placed inexpensively on anintegrated circuit doubles approximately every two years
![Page 31: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/31.jpg)
Is the Medical Progress the “Quiet Killer” of the System?
![Page 32: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/32.jpg)
medicalstandard
Additional costs
healthimprovement
worse and more expensive
better and cheaper
better and more expensive
cheaper and worse
What Makes a Medical Intervention Cost Effective?
![Page 33: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/33.jpg)
economically determined cost effectiveness
MedizinischerStandard
Additional costs
worse and more expensive
better and cheaper
better and more expensive
cheaper and worse
rational prioritization on the basis of individual benefit
We Need a New Paradigm
![Page 34: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/34.jpg)
Times of Biological Revolutions...
Decoding of the human genome in 2001: 3,2 x 109 genetic letters, ca. 25.000 genes
![Page 35: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/35.jpg)
These properties result from genomic variations.They are inherited and are therefore stored in all cells of
an individual.
These properties result from genomic variations.They are inherited and are therefore stored in all cells of
an individual.
Some 7 Billion Genomes exist on Earth
![Page 36: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/36.jpg)
inheritedfactors
acquired factors
The Sick Patient
![Page 37: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/37.jpg)
The Sick Patient
Disease results from a combination of inherited factors and acquired factors (mutations)
![Page 38: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/38.jpg)
The Sick Patient
any timefrom any cell
in case of a diseasefrom an affected cell
![Page 39: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/39.jpg)
Medical progress has failed to be scalable so far, but moleculardiagnostics will change that.
Molecular Diagnostics Will Become a Key Technology
![Page 40: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/40.jpg)
healthy
![Page 41: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/41.jpg)
healthy
at risk
![Page 42: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/42.jpg)
sick
healthy
at risk
![Page 43: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/43.jpg)
efficacious
![Page 44: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/44.jpg)
efficacious
partially efficacious
![Page 45: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/45.jpg)
ineffective
efficacious
partially efficacious
![Page 46: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/46.jpg)
tolerable
![Page 47: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/47.jpg)
tolerable
problematic
![Page 48: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/48.jpg)
toxic
tolerable
problematic
![Page 49: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/49.jpg)
Classical diagnostics:• Detection of diseases
Molecular diagnostics:• Detection of diseases• Detection of disease risks• Prediction of
drug efficacydrug tolerability
Prof. Dr. Theodor Dingermann – Personalized Medicine
Diagnostics
![Page 50: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/50.jpg)
Molecular diagnostics will provide the rationale for a personalized therapy and could help to make medical progress scalable.
Stratified Medicine = Efficacy & Effectiveness
![Page 51: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/51.jpg)
Stratified Medicine = Efficacy & Effectiveness
![Page 52: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/52.jpg)
Responder vs. Non-Responder
![Page 53: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/53.jpg)
Antibodies Directed Against EGFR
![Page 54: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/54.jpg)
Prof. Dr. Theodor Dingermann – Personalized Medicine
Antibodies Directed Against EGFR
![Page 55: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/55.jpg)
ADRADR--ResponderResponder
ResponderResponder
NonNon--ResponderResponder
Optimal therapy for every individual patient
Solutions Through Innovative Technologies
![Page 56: Innovative Biotechnologies for Human Healthcare … · Innovative Biotechnologies for Human Healthcare Prof. Theo Dingermann Institut für Pharmazeutische Biologie Biozentrum Max-von](https://reader034.fdocuments.us/reader034/viewer/2022042209/5eac7e066fbad44bf51cf00c/html5/thumbnails/56.jpg)
From Copying Towards Designing
THANK YOU VERY MUCH